-
1
-
-
0021867923
-
Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection
-
Kalser MH, Ellenberg SS, (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120: 899-903.
-
(1985)
Arch Surg
, vol.120
, pp. 899-903
-
-
Kalser, M.H.1
Ellenberg, S.S.2
-
2
-
-
12144287320
-
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
-
Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350: 1200-1210.
-
(2004)
N Engl J Med
, vol.350
, pp. 1200-1210
-
-
Neoptolemos, J.P.1
Stocken, D.D.2
Friess, H.3
Bassi, C.4
Dunn, J.A.5
-
3
-
-
33846405332
-
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial
-
Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, et al. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297: 267-277.
-
(2007)
JAMA
, vol.297
, pp. 267-277
-
-
Oettle, H.1
Post, S.2
Neuhaus, P.3
Gellert, K.4
Langrehr, J.5
-
4
-
-
40449113435
-
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial
-
Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, et al. (2008) Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 299: 1019-1026.
-
(2008)
JAMA
, vol.299
, pp. 1019-1026
-
-
Regine, W.F.1
Winter, K.A.2
Abrams, R.A.3
Safran, H.4
Hoffman, J.P.5
-
5
-
-
52149123619
-
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
-
Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
-
(2008)
Science
, vol.321
, pp. 1801-1806
-
-
Jones, S.1
Zhang, X.2
Parsons, D.W.3
Lin, J.C.4
Leary, R.J.5
-
6
-
-
33751212765
-
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience
-
Discussion 1210-1191
-
Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 10: 1199-1210; discussion 1210-1191.
-
(2006)
J Gastrointest Surg
, vol.10
, pp. 1199-1210
-
-
Winter, J.M.1
Cameron, J.L.2
Campbell, K.A.3
Arnold, M.A.4
Chang, D.C.5
-
7
-
-
58049202340
-
Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704
-
Berger AC, Garcia M Jr, Hoffman JP, Regine WF, Abrams RA, et al. (2008) Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol 26: 5918-5922.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5918-5922
-
-
Berger, A.C.1
Garcia Jr., M.2
Hoffman, J.P.3
Regine, W.F.4
Abrams, R.A.5
-
8
-
-
42949126637
-
Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature
-
Garcea G, Dennison AR, Pattenden CJ, Neal CP, Sutton CD, et al. (2008) Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. JOP 9: 99-132.
-
(2008)
JOP
, vol.9
, pp. 99-132
-
-
Garcea, G.1
Dennison, A.R.2
Pattenden, C.J.3
Neal, C.P.4
Sutton, C.D.5
-
9
-
-
3242671534
-
Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas
-
Brennan MF, Kattan MW, Klimstra D, Conlon K, (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240: 293-298.
-
(2004)
Ann Surg
, vol.240
, pp. 293-298
-
-
Brennan, M.F.1
Kattan, M.W.2
Klimstra, D.3
Conlon, K.4
-
10
-
-
77956340670
-
Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer
-
Kondo N, Murakami Y, Uemura K, Hayashidani Y, Sudo T, et al. (2010) Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer. Ann Surg Oncol 17: 2321-2329.
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 2321-2329
-
-
Kondo, N.1
Murakami, Y.2
Uemura, K.3
Hayashidani, Y.4
Sudo, T.5
-
11
-
-
79961021004
-
Pancreatic cancer surgery in the new millennium: better prediction of outcome
-
Hartwig W, Hackert T, Hinz U, Gluth A, Bergmann F, et al. (2011) Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg 254: 311-319.
-
(2011)
Ann Surg
, vol.254
, pp. 311-319
-
-
Hartwig, W.1
Hackert, T.2
Hinz, U.3
Gluth, A.4
Bergmann, F.5
-
12
-
-
77952973346
-
Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma
-
Barton JG, Bois JP, Sarr MG, Wood CM, Qin R, et al. (2009) Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma. J Gastrointest Surg 13: 2050-2058.
-
(2009)
J Gastrointest Surg
, vol.13
, pp. 2050-2058
-
-
Barton, J.G.1
Bois, J.P.2
Sarr, M.G.3
Wood, C.M.4
Qin, R.5
-
13
-
-
40749149728
-
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
-
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, et al. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371: 1007-1016.
-
(2008)
Lancet
, vol.371
, pp. 1007-1016
-
-
Nordlinger, B.1
Sorbye, H.2
Glimelius, B.3
Poston, G.J.4
Schlag, P.M.5
-
14
-
-
70350434889
-
Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma
-
Leao IC, Ganesan P, Armstrong TD, Jaffee EM, (2008) Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma. Clin Transl Sci 1: 228-239.
-
(2008)
Clin Transl Sci
, vol.1
, pp. 228-239
-
-
Leao, I.C.1
Ganesan, P.2
Armstrong, T.D.3
Jaffee, E.M.4
-
15
-
-
66849089420
-
A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity
-
Feng Y, Xiao X, Zhu Z, Streaker E, Ho M, et al. (2009) A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity. Mol Cancer Ther 8: 1113-1118.
-
(2009)
Mol Cancer Ther
, vol.8
, pp. 1113-1118
-
-
Feng, Y.1
Xiao, X.2
Zhu, Z.3
Streaker, E.4
Ho, M.5
-
16
-
-
54349091298
-
Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells
-
Showalter SL, Huang YH, Witkiewicz A, Costantino CL, Yeo CJ, et al. (2008) Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells. Cancer Biol Ther 7: 1584-1590.
-
(2008)
Cancer Biol Ther
, vol.7
, pp. 1584-1590
-
-
Showalter, S.L.1
Huang, Y.H.2
Witkiewicz, A.3
Costantino, C.L.4
Yeo, C.J.5
-
17
-
-
49149129916
-
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
-
Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, et al. (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14: 822-827.
-
(2008)
Nat Med
, vol.14
, pp. 822-827
-
-
Shedden, K.1
Taylor, J.M.2
Enkemann, S.A.3
Tsao, M.S.4
Yeatman, T.J.5
-
18
-
-
19944422061
-
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
-
Paik S, Shak S, Tang G, Kim C, Baker J, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817-2826.
-
(2004)
N Engl J Med
, vol.351
, pp. 2817-2826
-
-
Paik, S.1
Shak, S.2
Tang, G.3
Kim, C.4
Baker, J.5
-
19
-
-
83355166957
-
Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer
-
Gray RG, Quirke P, Handley K, Lopatin M, Magill L, et al. (2011) Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. J Clin Oncol 29: 4611-4619.
-
(2011)
J Clin Oncol
, vol.29
, pp. 4611-4619
-
-
Gray, R.G.1
Quirke, P.2
Handley, K.3
Lopatin, M.4
Magill, L.5
-
20
-
-
50549085619
-
Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy
-
Cheville JC, Karnes RJ, Therneau TM, Kosari F, Munz JM, et al. (2008) Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy. J Clin Oncol 26: 3930-3936.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3930-3936
-
-
Cheville, J.C.1
Karnes, R.J.2
Therneau, T.M.3
Kosari, F.4
Munz, J.M.5
-
21
-
-
77955048480
-
A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma
-
Stratford JK, Bentrem DJ, Anderson JM, Fan C, Volmar KA, et al. (2010) A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. PLoS Med 7: e1000307.
-
(2010)
PLoS Med
, vol.7
-
-
Stratford, J.K.1
Bentrem, D.J.2
Anderson, J.M.3
Fan, C.4
Volmar, K.A.5
-
22
-
-
65449141024
-
A compendium of potential biomarkers of pancreatic cancer
-
Harsha HC, Kandasamy K, Ranganathan P, Rani S, Ramabadran S, et al. (2009) A compendium of potential biomarkers of pancreatic cancer. PLoS Med 6: e1000046.
-
(2009)
PLoS Med
, vol.6
-
-
Harsha, H.C.1
Kandasamy, K.2
Ranganathan, P.3
Rani, S.4
Ramabadran, S.5
-
23
-
-
39049173392
-
The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysis
-
Boeck S, Ankerst DP, Heinemann V, (2007) The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysis. Oncology 72: 314-321.
-
(2007)
Oncology
, vol.72
, pp. 314-321
-
-
Boeck, S.1
Ankerst, D.P.2
Heinemann, V.3
-
24
-
-
0034043540
-
Quality of life and outcomes after pancreaticoduodenectomy
-
Huang JJ, Yeo CJ, Sohn TA, Lillemoe KD, Sauter PK, et al. (2000) Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 231: 890-898.
-
(2000)
Ann Surg
, vol.231
, pp. 890-898
-
-
Huang, J.J.1
Yeo, C.J.2
Sohn, T.A.3
Lillemoe, K.D.4
Sauter, P.K.5
-
25
-
-
83155172444
-
Intraductal papillary mucinous neoplasm
-
Shi C, Hruban RH, (2012) Intraductal papillary mucinous neoplasm. Hum Pathol 43: 1-16.
-
(2012)
Hum Pathol
, vol.43
, pp. 1-16
-
-
Shi, C.1
Hruban, R.H.2
-
26
-
-
2442568891
-
MUC1 and MUC2 in pancreatic neoplasia
-
Levi E, Klimstra DS, Andea A, Basturk O, Adsay NV, (2004) MUC1 and MUC2 in pancreatic neoplasia. J Clin Pathol 57: 456-462.
-
(2004)
J Clin Pathol
, vol.57
, pp. 456-462
-
-
Levi, E.1
Klimstra, D.S.2
Andea, A.3
Basturk, O.4
Adsay, N.V.5
-
27
-
-
0037407686
-
Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas
-
Adsay NV, Merati K, Nassar H, Shia J, Sarkar F, et al. (2003) Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol 27: 571-578.
-
(2003)
Am J Surg Pathol
, vol.27
, pp. 571-578
-
-
Adsay, N.V.1
Merati, K.2
Nassar, H.3
Shia, J.4
Sarkar, F.5
-
28
-
-
80052000345
-
Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer
-
Jain M, Venkatraman G, Moniaux N, Kaur S, Kumar S, et al. (2011) Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer. PLoS One 6: e23344.
-
(2011)
PLoS One
, vol.6
-
-
Jain, M.1
Venkatraman, G.2
Moniaux, N.3
Kaur, S.4
Kumar, S.5
-
29
-
-
62249176551
-
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer
-
Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, et al. (2009) DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27: 1806-1813.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1806-1813
-
-
Iacobuzio-Donahue, C.A.1
Fu, B.2
Yachida, S.3
Luo, M.4
Abe, H.5
-
30
-
-
84856462406
-
Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades
-
Winter JM, Brennan MF, Tang LH, D'Angelica MI, Dematteo RP, et al. (2012) Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Ann Surg Oncol 19: 169-175.
-
(2012)
Ann Surg Oncol
, vol.19
, pp. 169-175
-
-
Winter, J.M.1
Brennan, M.F.2
Tang, L.H.3
D'Angelica, M.I.4
Dematteo, R.P.5
-
31
-
-
80051928519
-
Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival
-
Arnaoutakis GJ, Rangachari D, Laheru DA, Iacobuzio-Donahue CA, Hruban RH, et al. (2011) Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival. J Gastrointest Surg 15: 1611-1617.
-
(2011)
J Gastrointest Surg
, vol.15
, pp. 1611-1617
-
-
Arnaoutakis, G.J.1
Rangachari, D.2
Laheru, D.A.3
Iacobuzio-Donahue, C.A.4
Hruban, R.H.5
-
32
-
-
80054861821
-
Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma
-
Einama T, Kamachi H, Nishihara H, Homma S, Kanno H, et al. (2011) Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma. Pancreas 40: 1276-1282.
-
(2011)
Pancreas
, vol.40
, pp. 1276-1282
-
-
Einama, T.1
Kamachi, H.2
Nishihara, H.3
Homma, S.4
Kanno, H.5
-
33
-
-
9144231784
-
Increased expression of MUC1 in advanced pancreatic cancer
-
Hinoda Y, Ikematsu Y, Horinochi M, Sato S, Yamamoto K, et al. (2003) Increased expression of MUC1 in advanced pancreatic cancer. J Gastroenterol 38: 1162-1166.
-
(2003)
J Gastroenterol
, vol.38
, pp. 1162-1166
-
-
Hinoda, Y.1
Ikematsu, Y.2
Horinochi, M.3
Sato, S.4
Yamamoto, K.5
-
34
-
-
66149100988
-
Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray
-
Takikita M, Altekruse S, Lynch CF, Goodman MT, Hernandez BY, et al. (2009) Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray. Cancer Res 69: 2950-2955.
-
(2009)
Cancer Res
, vol.69
, pp. 2950-2955
-
-
Takikita, M.1
Altekruse, S.2
Lynch, C.F.3
Goodman, M.T.4
Hernandez, B.Y.5
-
35
-
-
0035674996
-
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)
-
Argani P, Iacobuzio-Donahue C, Ryu B, Rosty C, Goggins M, et al. (2001) Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 7: 3862-3868.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 3862-3868
-
-
Argani, P.1
Iacobuzio-Donahue, C.2
Ryu, B.3
Rosty, C.4
Goggins, M.5
-
36
-
-
0036233702
-
MUC4 expression increases progressively in pancreatic intraepithelial neoplasia
-
Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, et al. (2002) MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol 117: 791-796.
-
(2002)
Am J Clin Pathol
, vol.117
, pp. 791-796
-
-
Swartz, M.J.1
Batra, S.K.2
Varshney, G.C.3
Hollingsworth, M.A.4
Yeo, C.J.5
-
37
-
-
33749340804
-
Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates
-
Jhala N, Jhala D, Vickers SM, Eltoum I, Batra SK, et al. (2006) Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates. Am J Clin Pathol 126: 572-579.
-
(2006)
Am J Clin Pathol
, vol.126
, pp. 572-579
-
-
Jhala, N.1
Jhala, D.2
Vickers, S.M.3
Eltoum, I.4
Batra, S.K.5
-
38
-
-
69049089548
-
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research
-
Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, et al. (2009) The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 15: 5323-5337.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5323-5337
-
-
Cheever, M.A.1
Allison, J.P.2
Ferris, A.S.3
Finn, O.J.4
Hastings, B.M.5
-
39
-
-
84863701766
-
Safety and Efficacy Study of 90Y-hPAM4 at Different Doses
-
Wegener W, (2008) Safety and Efficacy Study of 90Y-hPAM4 at Different Doses.
-
(2008)
-
-
Wegener, W.1
-
40
-
-
0034800607
-
Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer
-
Cardillo TM, Ying Z, Gold DV, (2001) Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer. Clin Cancer Res 7: 3186-3192.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 3186-3192
-
-
Cardillo, T.M.1
Ying, Z.2
Gold, D.V.3
-
41
-
-
0029807602
-
Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources
-
Chen L, Pulsipher M, Chen D, Sieff C, Elias A, et al. (1996) Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest 98: 2539-2548.
-
(1996)
J Clin Invest
, vol.98
, pp. 2539-2548
-
-
Chen, L.1
Pulsipher, M.2
Chen, D.3
Sieff, C.4
Elias, A.5
-
42
-
-
0033805534
-
Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen
-
Kurihara T, Brough DE, Kovesdi I, Kufe DW, (2000) Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen. J Clin Invest 106: 763-771.
-
(2000)
J Clin Invest
, vol.106
, pp. 763-771
-
-
Kurihara, T.1
Brough, D.E.2
Kovesdi, I.3
Kufe, D.W.4
-
43
-
-
50349083397
-
A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer
-
Tsuruta Y, Pereboeva L, Breidenbach M, Rein DT, Wang M, et al. (2008) A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer. Clin Cancer Res 14: 3582-3588.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3582-3588
-
-
Tsuruta, Y.1
Pereboeva, L.2
Breidenbach, M.3
Rein, D.T.4
Wang, M.5
-
44
-
-
84862991636
-
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis
-
Hollevoet K, Reitsma JB, Creaney J, Grigoriu BD, Robinson BW, et al. (2012) Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. J Clin Oncol 30: 1541-1549.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1541-1549
-
-
Hollevoet, K.1
Reitsma, J.B.2
Creaney, J.3
Grigoriu, B.D.4
Robinson, B.W.5
-
45
-
-
84860432624
-
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers
-
Sharon E, Zhang J, Hollevoet K, Steinberg SM, Pastan I, et al. (2011) Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers. Clin Chem Lab Med.
-
(2011)
Clin Chem Lab Med
-
-
Sharon, E.1
Zhang, J.2
Hollevoet, K.3
Steinberg, S.M.4
Pastan, I.5
-
46
-
-
33646415964
-
Multiple-criterion evaluation of reported mutations: a proposed scoring system for the intragenic somatic mutation literature
-
Winter JM, Brody JR, Kern SE, (2006) Multiple-criterion evaluation of reported mutations: a proposed scoring system for the intragenic somatic mutation literature. Cancer Biol Ther 5: 360-370.
-
(2006)
Cancer Biol Ther
, vol.5
, pp. 360-370
-
-
Winter, J.M.1
Brody, J.R.2
Kern, S.E.3
-
47
-
-
34247382565
-
Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases
-
Cao D, Zhang Q, Wu LS, Salaria SN, Winter JW, et al. (2007) Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Mod Pathol 20: 570-578.
-
(2007)
Mod Pathol
, vol.20
, pp. 570-578
-
-
Cao, D.1
Zhang, Q.2
Wu, L.S.3
Salaria, S.N.4
Winter, J.W.5
-
48
-
-
77950327493
-
Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN)
-
Karamitopoulou E, Zlobec I, Tornillo L, Carafa V, Schaffner T, et al. (2010) Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). Pathology 42: 229-234.
-
(2010)
Pathology
, vol.42
, pp. 229-234
-
-
Karamitopoulou, E.1
Zlobec, I.2
Tornillo, L.3
Carafa, V.4
Schaffner, T.5
-
49
-
-
36049050395
-
Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma
-
Yu GZ, Zhu MH, Chen Y, Ni CR, Li FM, (2005) [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma]. Ai Zheng 24: 1398-1403.
-
(2005)
Ai Zheng
, vol.24
, pp. 1398-1403
-
-
Yu, G.Z.1
Zhu, M.H.2
Chen, Y.3
Ni, C.R.4
Li, F.M.5
-
50
-
-
1942508005
-
Expression of ATM protein and its relationship with p53 in pancreatic carcinoma with tissue array
-
Yu G, Zhu MH, Zhu Z, Ni CR, Zheng JM, et al. (2004) Expression of ATM protein and its relationship with p53 in pancreatic carcinoma with tissue array. Pancreas 28: 421-426.
-
(2004)
Pancreas
, vol.28
, pp. 421-426
-
-
Yu, G.1
Zhu, M.H.2
Zhu, Z.3
Ni, C.R.4
Zheng, J.M.5
-
51
-
-
80054835640
-
Claudin-18 is an early-stage marker of pancreatic carcinogenesis
-
Tanaka M, Shibahara J, Fukushima N, Shinozaki A, Umeda M, et al. (2011) Claudin-18 is an early-stage marker of pancreatic carcinogenesis. J Histochem Cytochem 59: 942-952.
-
(2011)
J Histochem Cytochem
, vol.59
, pp. 942-952
-
-
Tanaka, M.1
Shibahara, J.2
Fukushima, N.3
Shinozaki, A.4
Umeda, M.5
-
52
-
-
26844457138
-
Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape
-
Chen R, Yi EC, Donohoe S, Pan S, Eng J, et al. (2005) Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology 129: 1187-1197.
-
(2005)
Gastroenterology
, vol.129
, pp. 1187-1197
-
-
Chen, R.1
Yi, E.C.2
Donohoe, S.3
Pan, S.4
Eng, J.5
-
53
-
-
31544447773
-
Cytokeratin 20 expression identifies a subtype of pancreatic adenocarcinoma with decreased overall survival
-
Matros E, Bailey G, Clancy T, Zinner M, Ashley S, et al. (2006) Cytokeratin 20 expression identifies a subtype of pancreatic adenocarcinoma with decreased overall survival. Cancer 106: 693-702.
-
(2006)
Cancer
, vol.106
, pp. 693-702
-
-
Matros, E.1
Bailey, G.2
Clancy, T.3
Zinner, M.4
Ashley, S.5
-
54
-
-
77954956505
-
Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma
-
Ben QW, Wang JC, Liu J, Zhu Y, Yuan F, et al. (2010) Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma. Ann Surg Oncol 17: 2213-2221.
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 2213-2221
-
-
Ben, Q.W.1
Wang, J.C.2
Liu, J.3
Zhu, Y.4
Yuan, F.5
-
55
-
-
77951937872
-
Immunohistochemistry for cell polarity protein lethal giant larvae 2 differentiates pancreatic intraepithelial neoplasia-3 and ductal adenocarcinoma of the pancreas from lower-grade pancreatic intraepithelial neoplasias
-
Lisovsky M, Dresser K, Woda B, Mino-Kenudson M, (2010) Immunohistochemistry for cell polarity protein lethal giant larvae 2 differentiates pancreatic intraepithelial neoplasia-3 and ductal adenocarcinoma of the pancreas from lower-grade pancreatic intraepithelial neoplasias. Hum Pathol 41: 902-909.
-
(2010)
Hum Pathol
, vol.41
, pp. 902-909
-
-
Lisovsky, M.1
Dresser, K.2
Woda, B.3
Mino-Kenudson, M.4
-
56
-
-
79954423742
-
Down-regulation of Bax-interacting factor 1 in human pancreatic ductal adenocarcinoma
-
Coppola D, Helm J, Ghayouri M, Malafa MP, Wang HG, (2011) Down-regulation of Bax-interacting factor 1 in human pancreatic ductal adenocarcinoma. Pancreas 40: 433-437.
-
(2011)
Pancreas
, vol.40
, pp. 433-437
-
-
Coppola, D.1
Helm, J.2
Ghayouri, M.3
Malafa, M.P.4
Wang, H.G.5
-
57
-
-
84863681283
-
Role of prostate stem cell antigen in human pancreatic carcinoma: a tissue microarray-based study
-
Yang WB, Cai F, Cheng CT, Cao G, Qing ZY, (2009) [Role of prostate stem cell antigen in human pancreatic carcinoma: a tissue microarray-based study]. Nan Fang Yi Ke Da Xue Xue Bao 29: 2135-2137.
-
(2009)
Nan Fang Yi Ke Da Xue Xue Bao
, vol.29
, pp. 2135-2137
-
-
Yang, W.B.1
Cai, F.2
Cheng, C.T.3
Cao, G.4
Qing, Z.Y.5
-
58
-
-
33646021965
-
Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray
-
Chung GG, Yoon HH, Zerkowski MP, Ghosh S, Thomas L, et al. (2006) Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray. Cancer 106: 1677-1684.
-
(2006)
Cancer
, vol.106
, pp. 1677-1684
-
-
Chung, G.G.1
Yoon, H.H.2
Zerkowski, M.P.3
Ghosh, S.4
Thomas, L.5
-
59
-
-
51049099174
-
Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer
-
Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, et al. (2008) Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res 68: 6100-6108.
-
(2008)
Cancer Res
, vol.68
, pp. 6100-6108
-
-
Tong, Z.1
Kunnumakkara, A.B.2
Wang, H.3
Matsuo, Y.4
Diagaradjane, P.5
-
60
-
-
84868972987
-
Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma
-
Cates JM, Byrd RH, Fohn LE, Tatsas AD, Washington MK, et al. (2009) Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma. Pancreas 38: e1-6.
-
(2009)
Pancreas
, vol.38
-
-
Cates, J.M.1
Byrd, R.H.2
Fohn, L.E.3
Tatsas, A.D.4
Washington, M.K.5
-
61
-
-
68549135040
-
HOX D13 expression across 79 tumor tissue types
-
Cantile M, Franco R, Tschan A, Baumhoer D, Zlobec I, et al. (2009) HOX D13 expression across 79 tumor tissue types. Int J Cancer 125: 1532-1541.
-
(2009)
Int J Cancer
, vol.125
, pp. 1532-1541
-
-
Cantile, M.1
Franco, R.2
Tschan, A.3
Baumhoer, D.4
Zlobec, I.5
-
62
-
-
66549130709
-
Calponin is expressed in serous cystadenomas of the pancreas but not in adenocarcinomas or endocrine tumors
-
Marsh WL, Colonna J, Yearsley M, Bloomston M, Frankel WL, (2009) Calponin is expressed in serous cystadenomas of the pancreas but not in adenocarcinomas or endocrine tumors. Appl Immunohistochem Mol Morphol 17: 216-219.
-
(2009)
Appl Immunohistochem Mol Morphol
, vol.17
, pp. 216-219
-
-
Marsh, W.L.1
Colonna, J.2
Yearsley, M.3
Bloomston, M.4
Frankel, W.L.5
-
63
-
-
77953115071
-
Biological significance of expression of calcyclin in human pancreatic carcinoma: a tissue microarray-based study
-
Yang WB, Wang YH, Cai F, Cao G, Qin ZY, (2007) [Biological significance of expression of calcyclin in human pancreatic carcinoma: a tissue microarray-based study]. Nan Fang Yi Ke Da Xue Xue Bao 27: 1908-1910.
-
(2007)
Nan Fang Yi Ke Da Xue Xue Bao
, vol.27
, pp. 1908-1910
-
-
Yang, W.B.1
Wang, Y.H.2
Cai, F.3
Cao, G.4
Qin, Z.Y.5
-
64
-
-
77954214387
-
Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray
-
Morse DL, Balagurunathan Y, Hostetter G, Trissal M, Tafreshi NK, et al. (2010) Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray. Biochem Pharmacol 80: 748-754.
-
(2010)
Biochem Pharmacol
, vol.80
, pp. 748-754
-
-
Morse, D.L.1
Balagurunathan, Y.2
Hostetter, G.3
Trissal, M.4
Tafreshi, N.K.5
-
65
-
-
4444354564
-
Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer
-
Gray PJ Jr, Bearss DJ, Han H, Nagle R, Tsao MS, et al. (2004) Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer. Mol Cancer Ther 3: 641-646.
-
(2004)
Mol Cancer Ther
, vol.3
, pp. 641-646
-
-
Gray Jr., P.J.1
Bearss, D.J.2
Han, H.3
Nagle, R.4
Tsao, M.S.5
-
66
-
-
77954117118
-
Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis
-
Wen J, Park JY, Park KH, Chung HW, Bang S, et al. (2010) Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis. Pancreas 39: 622-626.
-
(2010)
Pancreas
, vol.39
, pp. 622-626
-
-
Wen, J.1
Park, J.Y.2
Park, K.H.3
Chung, H.W.4
Bang, S.5
-
67
-
-
41449091030
-
Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis
-
Pham NA, Schwock J, Iakovlev V, Pond G, Hedley DW, et al. (2008) Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis. BMC Cancer 8: 43.
-
(2008)
BMC Cancer
, vol.8
, pp. 43
-
-
Pham, N.A.1
Schwock, J.2
Iakovlev, V.3
Pond, G.4
Hedley, D.W.5
|